These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5569050)

  • 21. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dietary treatment with clofibrate, nafenopin or WY-14.643 on mitochondria and DNA in mouse liver.
    Lundgren B; Bergstrand A; Karlsson K; DePierre JW
    Biochim Biophys Acta; 1990 Aug; 1035(2):132-8. PubMed ID: 2393663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clofibrate, fibrinolysis, and platelet stickiness.
    Fearnley GR
    Br Med J; 1970 Oct; 4(5727):114. PubMed ID: 5471757
    [No Abstract]   [Full Text] [Related]  

  • 24. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth and liver glycerophosphate dehydrogenase response to thyroxine and p-chlorophenoxyisobutyrate.
    Richert DA; Westerfeld WW
    Endocrinology; 1970 Dec; 87(6):1274-81. PubMed ID: 5529883
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of clofibrate on the serum triglyceride concentration in normal males fed high-sucrose diets.
    Zakim D; Herman RH
    J Atheroscler Res; 1969; 10(1):91-5. PubMed ID: 5380907
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of short-term use of clofibrate on the blood level of cholesterol, beta lipoproteins and free fatty acids].
    Modzelewski A; Zaczek-Modzelewska T
    Wiad Lek; 1970 Nov; 23(21):1937-9. PubMed ID: 5485649
    [No Abstract]   [Full Text] [Related]  

  • 28. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
    Araki Y; Amagase H
    Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the assay, activity and sedimentation behaviour of acetyl-CoA carboxylase from isolated hepatocytes incubated with insulin or glucagon.
    Buechler KF; Beynen AC; Geelen MJ
    Biochem J; 1984 Aug; 221(3):869-74. PubMed ID: 6148077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.
    Sodhi HS; Kudchodkar BJ; Horlick L; Weder CH
    Metabolism; 1971 Apr; 20(4):348-59. PubMed ID: 5550302
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fibrinolytic action of aluminum bis-alpha-para-chlorophenoxy isobutyrate].
    Daver J; Ripoll S; Du Pasquier JP; Edmond E; Palus JC; Ricoeur M; Aubert D
    Therapie; 1969; 24(3):419-28. PubMed ID: 5399537
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity.
    Tolman EL; Tepperman HM; Tepperman J
    Am J Physiol; 1970 May; 218(5):1313-8. PubMed ID: 4314568
    [No Abstract]   [Full Text] [Related]  

  • 33. Stimulation by a tumor-promoting phorbol ester of acetyl-CoA carboxylase activity in isolated rat hepatocytes.
    Vaartjes WJ; de Haas CG; Geelen MJ; Bijleveld C
    Biochem Biophys Res Commun; 1987 Jan; 142(1):135-40. PubMed ID: 2880584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lentysine: a new hypolipidemic agent from a mushroom.
    Rokujo T; Kikuchi H; Tensho A; Tsukitani Y; Takenawa T; Yoshida K; Kamiya T
    Life Sci; 1970 Apr; 9(7):379-85. PubMed ID: 5463059
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
    Samuel P; Holtzman CM; Meilman E; Sekowski I
    Circulation; 1970 Jan; 41(1):109-14. PubMed ID: 5420622
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability.
    Brass EP
    J Nutr; 1992 Feb; 122(2):234-40. PubMed ID: 1732464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of clofibrate administration on the esterification and deesterification of steroid hormones by liver and extrahepatic tissues in rats.
    Xu S; Zhu BT; Conney AH
    Biochem Pharmacol; 2002 Mar; 63(5):985-92. PubMed ID: 11911851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of protein synthesis in the carbohydrate-induced changes in the activities of acetyl-CoA carboxylase and hydroxymethylglutaryl-CoA reductase in cultured rat hepatocytes.
    Spence JT; Koudelka AP; Tseng-Crank JC
    Biochem J; 1985 May; 227(3):939-47. PubMed ID: 2860899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of clofibrate administration on the urinary vanilmandelic acid method of Pisano et al.
    Sacre MH; Walker G
    Clin Chim Acta; 1970 Oct; 30(1):215-7. PubMed ID: 5473568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.